biotech / news / / Bloomberg
Eli Lilly & Co. is spending another $4.5 billion on its manufacturing plants in Indiana.
Eli Lilly is investing an additional $4.5 billion in its Indiana manufacturing plants.
KEY POINTS
- The investment includes technology upgrades at Lilly’s first dedicated genetic medicine facility.
- A new facility opening in 2027 will be the largest U.S. producer of active pharmaceutical ingredients.
- Both facilities are located in Lebanon, Indiana, approximately 27 miles from Indianapolis.
COMPANIES
Summarized by Newsio from Bloomberg. How we summarize →